Table 1. Baseline demographic, clinical, and laboratory data of group A and group Ba

Group AGroup B
a Data from group A were obtained within 1 wk before transplant nephrectomy. Data are mean ± SD. GN, glomerulonephritis; DN, diabetic nephropathy; CIN, chronic interstitial nephropathy; APCD, adult polycystic disease; Hb, hemoglobin; ERI, erythropoietin resistance index; TSI, transferring saturation index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; iPTH, intact parathyroid hormone; NS, no significance.
Significance between groups A and B at baseline: b P < 0.001;
c P < 0.05.
N43121
Age (yr)48.6 ± 14.6b62.9 ± 13.8
Gender (% male)55.863.2
Cause of chronic renal failureGN (32.5%), DN (14%), CIN (11.6%), APCD (20.9%)GN (22.6%), DN (19.5%), CIN (20.3%), APCD (16.5%)
Hb (g/dl)10.4 ± 1.9b12.7 ± 1.4
rHu-EPO dose (U/wk)8862 ± 3924b6380 ± 3706
ERI (U/kg per wk per g/dl)16.1 ± 9.0b8.3 ± 5.5
Ferritin (μg/L)469 ± 382NS412 ± 320
TSI (%)26.7 ± 10.7NS34.5 ± 15
Albumin (g/dl)3.2 ± 0.6b3.8 ± 0.4
Prealbumin (mg/dl)25.3 ± 12.1b32.3 ± 7.8
Cholesterol (mg/dl)181.3 ± 42.7NS191.4 ± 39.5
CRP (mg/dl)4.1 ± 4.7b1.3 ± 1.9
iPTH (pg/ml)258.3 ± 271.3c386 ± 400